Barriers to Alzheimer disease drug discovery and development in academia

Alzheimer Disease and Associated Disorders

Volumn 16, Issue SUPPL. 1, 2002, Pages

  Van Eldik, Linda J ^a   Koppal, Tanuja ^a   Watterson, D Martin ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemistry; Drug discovery and development; Neurodegenerative disorders; Pharmacology

Indexed keywords

ALZHEIMER DISEASE; BIOTECHNOLOGY; DEGENERATIVE DISEASE; DRUG APPROVAL; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0036285427     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200200001-00004     Document Type: Review

References (14)

1. Playing the economics game with outsourcing
2. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen
3. Alzheimer's disease and its management in the year 2010
4. Infrastructure for research on aging rodents: Need for regional facilities to support transgenic studies on aging
5. Oursourcing the search for leads
6. The HIV protease and therapies for AIDS
7. Human immunodeficiency virus protease inhibitors. From drug design to clinical studies
8. Drug discovery in the next millenium
9. Development of HIV protease inhibitors: A survey
10. HIV protease inhibitors: Pharmacologic and metabolic distinctions
11. Chemical biology: Information, mesoscale science and the engineering ethos
12. Chemical biology: The promise, and confusion, of adolescence